Overview: Carrier Status TestIntroduction: The Carrier Status Test tests for genetic mutations to determine if you carry genes for inherited disorders, helping assess risk for passing conditions like cystic fibrosis to children. Affecting 1 in 25 people as carriers, these mutations pose diagnostic challenges due to asymptomatic carriers. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses PCR/sequencing for high accuracy, supporting molecular pathology screening. This test is vital for genetic counseling and family planning.
Other Names: Genetic Carrier Screening, Carrier Mutation Test.
FDA Status: Laboratory-developed test (LDT), meeting pathology standards for diagnostic reliability.
Historical Milestone: Carrier testing began in the 1970s with research by Kaback, who identified Tay-Sachs carriers. PCR/sequencing advancements in the 2000s by Illumina improved detection, surpassing earlier Southern blot methods.
Purpose: Detects genetic mutations to assess carrier status, guides reproductive decisions, and evaluates individuals with family history, aiming to inform risk and prevention.
Test Parameters: Genetic mutation status
Pretest Condition: No special preparation required. Collect whole blood, buccal swab, or saliva. Report family history.
Specimen: Whole Blood (EDTA, 3-5 mL), Buccal Swab (sterile swab, 1-2 swabs), Saliva (sterile container, 1-2 mL); 4 mL whole blood in EDTA tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document family history of genetic disorders. Include current medications or ethnicity.
Consent: Written consent required, detailing the test's purpose, carrier risks (e.g., offspring disease), and sample collection risks.
Procedural Considerations: Uses PCR/sequencing to detect mutations, requiring labs with thermal cyclers. Results available in 5-7 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Prior treatments may not affect results but require correlation.
Clinical Significance: Positive mutations indicate carrier status, guiding counseling. Early awareness might enable prenatal testing, while negative results reduce concern. Normal results may require partner testing.
Specialist Consultation: Consult a genetic counselor for interpretation.
Additional Supporting Tests: Partner carrier test, prenatal screening, or genetic panel to confirm risk.
Test Limitations: Specific to tested mutations; correlation with family history needed. False negatives possible with untested variants.
References: ACMG Guidelines, 2023; Genetics in Medicine, Kaback MM, 2022.
